cro.directory
← Compare landing

Cyagen Biosciences vs Esco Aster

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/apac-cyagen/escoaster

CategoryCyagen BiosciencesEsco Aster
Listed sitecroboth
SummaryCyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.Esco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology.
Services
  • Specialized & Large-Animal Models
  • Preclinical In Vivo Studies
  • Preclinical In Vitro Studies
  • In Vivo Efficacy Models
  • Translational Research
  • Discovery Research
  • Translational Research
  • Clinical Trial Services
  • GLP Toxicology
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
Modalities
  • Biologics (Monoclonal Antibodies)
  • Oligonucleotide
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Rare Disease
  • Ophthalmology
  • Neurology
  • Infectious Disease
  • Respiratory
  • Dermatology
Locations
  • Headquarters, Santa Clara, California, United States
Data not yet provided.
Certifications
  • AAALAC · Identifier: AAALAC-accredited facilities
  • cGMP · Identifier: cGMP-compliant
  • GLP · Identifier: GLP Toxicology
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.